Sanford C. Bernstein Forecasts Strong Price Appreciation for CVS Health (NYSE:CVS) Stock

CVS Health (NYSE:CVS) had its price objective boosted by investment analysts at Sanford C. Bernstein from $94.00 to $106.00 in a note issued to investors on Tuesday, Marketbeat Ratings reports. The firm presently has an “outperform” rating on the pharmacy operator’s stock. Sanford C. Bernstein’s price objective points to a potential upside of 8.00% from the stock’s current price.

CVS has been the subject of several other research reports. HSBC lifted their price target on shares of CVS Health from $83.00 to $85.00 and gave the company a “hold” rating in a research note on Tuesday, May 5th. Deutsche Bank Aktiengesellschaft raised their price objective on CVS Health from $88.00 to $92.00 and gave the stock a “buy” rating in a report on Thursday, May 7th. Wolfe Research lowered their target price on CVS Health from $100.00 to $97.00 and set an “outperform” rating for the company in a report on Monday, March 2nd. Leerink Partners restated an “outperform” rating and set a $98.00 price target on shares of CVS Health in a research note on Thursday, March 5th. Finally, Piper Sandler lowered their price objective on shares of CVS Health from $101.00 to $99.00 and set an “overweight” rating for the company in a research note on Tuesday, March 31st. Twenty-two equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat, CVS Health has an average rating of “Moderate Buy” and an average price target of $97.00.

CVS Health Stock Up 3.1%

NYSE:CVS opened at $98.14 on Tuesday. The company has a market cap of $125.22 billion, a price-to-earnings ratio of 43.24, a price-to-earnings-growth ratio of 0.93 and a beta of 0.60. CVS Health has a twelve month low of $58.35 and a twelve month high of $98.22. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.78. The stock has a fifty day simple moving average of $78.07 and a 200-day simple moving average of $78.36.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, May 6th. The pharmacy operator reported $2.57 EPS for the quarter, topping the consensus estimate of $2.21 by $0.36. CVS Health had a net margin of 0.72% and a return on equity of 11.88%. The company had revenue of $100.43 billion for the quarter, compared to the consensus estimate of $94.99 billion. During the same quarter last year, the firm posted $2.25 EPS. The firm’s revenue was up 6.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.300-7.500 EPS. Analysts anticipate that CVS Health will post 7.46 EPS for the current year.

Insider Transactions at CVS Health

In related news, EVP Tilak Mandadi sold 69,551 shares of the business’s stock in a transaction that occurred on Friday, May 8th. The shares were sold at an average price of $89.58, for a total transaction of $6,230,378.58. Following the completion of the transaction, the executive vice president owned 10,133 shares in the company, valued at $907,714.14. The trade was a 87.28% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.85% of the stock is owned by company insiders.

Institutional Trading of CVS Health

Large investors have recently bought and sold shares of the stock. Alteri Wealth LLC grew its holdings in shares of CVS Health by 3.2% during the third quarter. Alteri Wealth LLC now owns 4,195 shares of the pharmacy operator’s stock valued at $316,000 after buying an additional 131 shares during the last quarter. TOWER TRUST & INVESTMENT Co lifted its holdings in shares of CVS Health by 0.8% during the fourth quarter. TOWER TRUST & INVESTMENT Co now owns 15,708 shares of the pharmacy operator’s stock worth $1,247,000 after purchasing an additional 132 shares during the period. Holistic Financial Partners increased its holdings in CVS Health by 4.1% in the 3rd quarter. Holistic Financial Partners now owns 3,397 shares of the pharmacy operator’s stock worth $256,000 after buying an additional 133 shares during the period. CYBER HORNET ETFs LLC raised its position in CVS Health by 4.1% during the 3rd quarter. CYBER HORNET ETFs LLC now owns 3,442 shares of the pharmacy operator’s stock worth $259,000 after buying an additional 134 shares during the last quarter. Finally, LS Investment Advisors LLC boosted its holdings in shares of CVS Health by 3.9% in the 4th quarter. LS Investment Advisors LLC now owns 3,575 shares of the pharmacy operator’s stock valued at $284,000 after acquiring an additional 135 shares during the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health News Summary

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Analysts at JPMorgan and Sanford C. Bernstein raised their price targets on CVS Health, reinforcing confidence that the stock still has room to run after strong quarterly results. Analyst target raises and company news
• Positive Sentiment: CVS Health won Gold in Enterprise AI and Silver in Customer Experience AI at the 2026 Stevie Awards, highlighting continued progress in using technology to improve operations and customer service. CVS Health wins awards for AI innovation
• Positive Sentiment: MinuteClinic is expanding its clinically supervised weight-loss and preventive care offerings, which supports CVS’s broader strategy to grow higher-value healthcare services. MinuteClinic weight-loss program
• Positive Sentiment: Omnicare, a CVS subsidiary, received court approval to sell its business to GenieRx, removing uncertainty around a distressed asset and potentially simplifying CVS’s portfolio. Reuters Omnicare sale approval

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.